The improvement in overall survival in ovarian cancer individuals treated with cisplatin after implementing visfatin antagonists to the therapy indicates that adipokines pose a potential therapeutic target for individual ovarian cancer treatment strategies. The gene discussed is NAMPT; the disease is ovarian cancer.